About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Georgia | 189 Studies

Clinical Trials Pancreatic CancerGeorgia

Pancreatic Cancer Clinical Trials in Georgia

Find 189 clinical trials for pancreatic cancer near Georgia. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Georgia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 189 trials

TerminatedPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerThis phase II trial studies how well real-time pharmacokinetic therapeutic drug monitoring works in preventing stomatitis from developing in patients with hormone receptor…NCT02273752·Atlanta, Georgia and 1 other CompletedGemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryThis randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy regimen with or without radiation…NCT01013649·Mobile, Alabama and 688 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedChemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049348·Scottsdale, Arizona and 136 others

RecruitingPancreatic Cancer Detection Consortium (PCDC) Prospective CohortsThis study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect…NCT06271291·Scottsdale, Arizona and 10 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedA Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerThis is an open label, multi-center, multi-arm, dose-escalation study of BBI608 administered in combination with Gemcitabine and nab-Paclitaxel, mFOLFIRINOX, FOLFIRI, or MM-398…NCT02231723·Phoenix, Arizona and 11 others

CompletedMEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.The objective of this study is to evaluate the safety, tolerability, and antitumor activity of oleclumab (MEDI9447) in combination with or without durvalumab plus chemotherapy in…NCT03611556·La Jolla, California and 26 others

CompletedPEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerThis study is designed to compare the treatment effect of PEGPH20 combined with nab-paclitaxel (NAB) and gemcitabine (GEM) \[PAG\] to NAB and GEM \[AG\] in participants with Stage…NCT01839487·Birmingham, Alabama and 50 others

CompletedStudy to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic AdenocarcinomaThe purpose of this study is to determine whether CO-1.01 is safe and effective for treating metastatic pancreatic cancer that did not respond to gemcitabine.NCT01233375·Tucson, Arizona and 12 others

CompletedPembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerThis phase Ib trial studies the side effects and best dose of Hsp90 inhibitor XL888 when given together with pembrolizumab in treating patients with advanced gastrointestinal…NCT03095781·Atlanta, Georgia and 2 others

CompletedRollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsThis is an open-label, multi-center, multi-national, non-randomized rollover study designed to allow continued access to napabucasin for patients who have participated in a Boston…NCT04299880·Atlanta, Georgia and 6 others

Active not recruitingA Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)The purpose of this study is to assess the safety and efficacy of Navlimetostat (BMS-986504), a selective, MTA-cooperative PRMT5 inhibitor, in combination with…NCT07076121·Phoenix, Arizona and 268 others

CompletedStudy of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerTo compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.NCT02923921·Gilbert, Arizona and 129 others

Active not recruitingCisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine CarcinomasThis randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients…NCT02595424·Kingman, Arizona and 672 others

CompletedA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib.NCT00428220·Atlanta, Georgia and 112 others

CompletedA Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsThis is a Phase I, open-label, multi-center, competitive enrollment and dose-escalation study of ALT-836 in combination with standard of care gemcitabine in participants who have…NCT01325558·Atlanta, Georgia and 3 others

CompletedTrial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic CancerThe primary objective of this study is to compare the overall survival of patients with stage IV pancreatic cancer treated with gemcitabine alone or gemcitabine with bavituximab.NCT01272791·Chandler, Arizona and 18 others

Active not recruitingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a…NCT03785249·Birmingham, Alabama and 221 others

RecruitingPancreatic Cancer Early Detection ConsortiumThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal…NCT04970056·Phoenix, Arizona and 61 others

RecruitingA Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaThe purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal…NCT07522073·Birmingham, Alabama and 229 others

PreviousPage 9 of 10Next

Other Conditions in Georgia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia